High Point Clinical Trials Center

Founded in 2008, High Point Clinical Trials Center has evolved from Transtech Pharma into a leading clinical research facility in the United States. With a focus on supporting the biopharmaceutical industry, the company specializes in conducting Phase 1/First in Human and Proof Of Concept Studies. High Point Clinical Trials Center collaborates with global biopharmaceutical entities, including CROs, virtual companies, and pharmaceutical clients, to deliver timely and high-quality data for early stage and POC studies involving healthy participants and patient populations. The company's commitment to participant safety, protocol adherence, regulatory compliance, and effective communication sets them apart in the industry. With a strong emphasis on pushing the boundaries and being the best in the business, High Point Clinical Trials Center has positioned itself as a vital partner for accelerating the drug development process. Despite limited information on recent investments and investors, the company's dedication to advancing clinical pharmacology research presents a compelling opportunity for potential venture capital involvement.